MedTrace Logo

Adipose Derived Regenerative Cellular Therapy of Chronic Wounds

NCT02092870 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2019-09-11

No results posted yet for this study

Summary

Our study aims to explore the effects of Adipose Derived Stem Cells (ASCs) on chronic wounds.

Conditions

  • Diabetic Foot
  • Venous Ulcer
  • Pressure Ulcer

Interventions

DRUG

Adipose derived stem cells

ASCs harvested from autologous lipoaspirate

Sponsors & Collaborators

  • Tower Outpatient Surgical Center

    lead OTHER

Principal Investigators

  • Joel A. Aronowitz, M.D. · Tower Multispecialty Medical Group

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2015-09-30
Completion
2019-09-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02092870 on ClinicalTrials.gov